Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cancer cells subvert the primate-specific KRAB zinc finger protein ZNF93 to control APOBEC3B. | Proc Natl Acad Sci U S A | 2025 | 40828019 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection heightens the risk of developing HPV-related carcinoma in situ and cancer. | Discov Oncol | 2025 | 40813533 | PubTator, text mining | PubMed |
| C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia. | Sci Rep | 2025 | 40813454 | PubTator, text mining | PubMed |
| The role of APOBEC mutagenesis in the progression and therapeutic guidance of pancreatic cancer. | Genomics | 2025 | 40812519 | PubTator, text mining | PubMed |
| TRDMT1 methyltransferase gene knockout attenuates STING-based cell death signaling during self-extracellular RNA-mediated response in drug-induced senescent osteosarcoma cells. | Cell Mol Life Sci | 2025 | 40801921 | PubTator, text mining | PubMed |
| A feasibility study of enzymatic methylation sequencing of cell-free DNA from cerebrospinal fluid of pediatric central nervous system tumor patients for molecular classification. | Neurooncol Adv | 2025 | 40746948 | PubTator, text mining | PubMed |
| A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron. | Nat Commun | 2025 | 40730568 | PubTator, text mining | PubMed |
| Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations. | Adv Sci (Weinh) | 2025 | 40548648 | PubTator, text mining | PubMed |
| Protocol for genetic dissection of class switch recombination using genome-editing tools. | STAR Protoc | 2025 | 40482035 | PubTator, text mining | PubMed |
| Bisulfite-free whole-genome mapping of 5-methylcytosine at single-base resolution by NTD-seq. | Sci China Life Sci | 2025 | 40418523 | PubTator, text mining | PubMed |
| Author Correction: Efficient C-to-T base editing in plants using a fusion of nCas9 and human APOBEC3A. | Nat Biotechnol | 2025 | 40379899 | PubTator, text mining | PubMed |
| DNA hairpin base-flipping dynamics drives APOBEC3A recognition and selectivity. | Phys Chem Chem Phys | 2025 | 40371934 | PubTator, text mining | PubMed |
| Characteristics of lung sounds in early infants using automated analysis. | Eur J Pediatr | 2025 | 40358760 | PubTator, text mining | PubMed |
| Direct single-nucleotide resolution sequencing of DNA 5-methylcytosine using engineered DNA methyltransferase-mediated CMD-seq. | Chem Sci | 2025 | 40276634 | PubTator, text mining | PubMed |
| Purification of enzymatically active APOBEC proteins from an insect cell expression system. | Methods Enzymol | 2025 | 40250960 | PubTator, text mining | PubMed |
| An in vitro cytidine deaminase assay to monitor APOBEC activity on DNA. | Methods Enzymol | 2025 | 40250954 | PubTator, text mining | PubMed |
| Defining APOBEC-induced mutation signatures and modifying activities in yeast. | Methods Enzymol | 2025 | 40250951 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Roles of APOBEC3 Gene Family in Clear Cell Renal Cell Carcinoma. | Arch Esp Urol | 2025 | 40191862 | PubTator, text mining | PubMed |
| Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stability. | Nucleic Acids Res | 2025 | 40156866 | PubTator, text mining | PubMed |
| APOBEC3 Proteins: From Antiviral Immunity to Oncogenic Drivers in HPV-Positive Cancers. | Viruses | 2025 | 40143363 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=4